.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cerilliant
Healthtrust
Daiichi Sankyo
Deloitte
Johnson and Johnson
Citi
AstraZeneca
UBS
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

Jazz Pharms Intl Company Profile

« Back to Dashboard

What is the competitive landscape for JAZZ PHARMS INTL, and when can generic versions of JAZZ PHARMS INTL drugs launch?

JAZZ PHARMS INTL has one approved drug.

There are four US patents protecting JAZZ PHARMS INTL drugs.

There are fifteen patent family members on JAZZ PHARMS INTL drugs in nine countries and two supplementary protection certificates in two countries.

Summary for Jazz Pharms Intl

International Patents:15
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-002Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-004Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-002Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-001Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-004Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-001Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-002Dec 28, 2004RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Jazz Pharms Intl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-002Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-004Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-004Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-001Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-001Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-001Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-002Dec 28, 2004► Subscribe► Subscribe
Jazz Pharms IntlPRIALTziconotide acetateINJECTABLE;INTRATHECAL021060-003Dec 28, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Jazz Pharms Intl

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,268,109Method for reducing pain► Subscribe
8,268,774Method for reducing pain► Subscribe
5,587,454 Omega conopeptide compositions► Subscribe
7,524,812Pharmaceutical formulation comprising ziconotide► Subscribe
8,513,198Pharmaceutical formulation for reducing pain► Subscribe
7,833,973Pharmaceutical formulations for reducing pain► Subscribe
6,136,786 Method for enhancing analgesia► Subscribe
5,994,305 Method of treating inflammation► Subscribe
7,956,030Method for reducing pain with ziconotide and baclofen► Subscribe
6,087,091 Method of selecting a compound for producing analgesia► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Jazz Pharms Intl Drugs

Country Document Number Estimated Expiration
European Patent Office0625162► Subscribe
Germany69225499► Subscribe
Hong Kong1013832► Subscribe
Australia3428093► Subscribe
Singapore50624► Subscribe
Australia689438► Subscribe
Japan2007507538► Subscribe
European Patent Office1689401► Subscribe
Canada2930900► Subscribe
Austria165977► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Jazz Pharms Intl Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0027France► SubscribePRODUCT NAME: ZICONOTIDE; REGISTRATION NO/DATE IN FRANCE: EU/1/04/302/001 DU 20050221; REGISTRATION NO/DATE AT EEC: EU/1/04/302/001-003 DU 20050221
C/GB05/033United Kingdom► SubscribePRODUCT NAME: ZICONOTIDE, OPTIONALLY IN THE FORM OF A SALT WITH A PHARMACEUTICALLY ACCEPTABLE ACID, INCLUDING ZICONOTIDE ACETATE; REGISTRATION NO/DATE: EU/1/04/302/001 - 003 20050224
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
UBS
Cantor Fitzgerald
Novartis
Mallinckrodt
US Army
Fuji
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot